Unknown

Dataset Information

0

In vivo response of EpCAM+ pancreatic cancer cells to gemcitabine plus anti-LIF neutralizing antibody treatment


ABSTRACT: The goal of this study is to investigate the molecular mechanisms of LIF action on pancreatic cancer cells in the classical pancreatic ductal adenocarcinoma mouse model KrasLSL-G12D;Tp53f/f;Rosa26LSL-Luc;Pdx1-Cre mice EpCAM+ pancreatic cancer cells were isolated from pancreatic tumors developped in KrasLSL-G12D;Tp53f/f;Rosa26LSL-Luc;Pdx1-Cre mice treated with either gemcitabine plus control IgG or gemcitabine plus anti-LIF antibody by FACS

ORGANISM(S): Mus musculus

PROVIDER: GSE99187 | GEO | 2018/12/21

REPOSITORIES: GEO

Similar Datasets

2018-12-21 | GSE119694 | GEO
2021-09-06 | E-MTAB-9843 | biostudies-arrayexpress
2021-09-06 | E-MTAB-9966 | biostudies-arrayexpress
2021-09-06 | E-MTAB-9972 | biostudies-arrayexpress
2021-09-06 | E-MTAB-10722 | biostudies-arrayexpress
2012-01-24 | E-GEOD-33323 | biostudies-arrayexpress
2012-01-24 | E-GEOD-33322 | biostudies-arrayexpress
2022-04-08 | GSE157134 | GEO
2024-01-29 | GSE195914 | GEO
| PRJNA155479 | ENA